Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Kamitori, S.; Ohtaki, A.; Ino, H.; Takeuchi, M.
    Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution (2003), J. Mol. Biol., 326, 1503-1511.
    View publication on PubMed

Crystallization (Commentary)

EC Number Crystallization (Comment) Organism
3.4.23.18 vapor diffusion method, crystallized in an orthorhombic system, space group P2(1)2(1)2(1), cell dimensions a : 49.4A, be : 79.4 A, c : 93.6 A, soaking method in complex with inhibitor pepstatin, crystals are transformed into a monoclinic system with space group C2 and cell dimensions of a : 106.8 A, be : 38.6 A, c : 78.7 A Aspergillus oryzae

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.4.23.18 pepstatin
-
 Aspergillus oryzae

Molecular Weight [Da]

EC Number Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
3.4.23.18 33790
-
 amino acid sequence Aspergillus oryzae

Organism

EC Number Organism UniProt Comment Textmining
3.4.23.18 Aspergillus oryzae
-
 var. globosus M-9
-

Purification (Commentary)

EC Number Purification (Comment) Organism
3.4.23.18
-
 Aspergillus oryzae

Synonyms

EC Number Synonyms Comment Organism
3.4.23.18 AOAP
-
 Aspergillus oryzae
3.4.23.18 Aspartic proteinase
-
 Aspergillus oryzae